✦ LIBER ✦

Donor KIR 3DS1 is Associated with Less Acute GvHD Following Unrelated Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

✍ Scribed by J.M. Venstrom; T.A. Gooley; S.R. Spellman; R.S. Hasan; J.A. Pring; M. Malkki; B. Dupont; E.W. Petersdorf; K.C. Hsu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Donor KIR2DS1 and KIR3DS1 Are Associated

✍ J.M. Venstrom; G. Pittari; J. Chewning; T.A. Gooley; S. Spellman; M. Haagenson; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Outcomes associated with a steroid-conta

✍ B. Hayes-Lattin; J.F. Leis; P.T. Curtin; A. Dunn; E. Epner; W.H. Fleming; T. Kov 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Donor KIR Genes 2DL5A, 2DS1 and 3DS1 Are

✍ Kate Stringaris; Sharon Adams; Marcela Uribe; Rhoda Eniafe; Colin O. Wu; Bipin N 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 260 KB

The Relapse-Free Survival Benefit Associ

✍ S. Cooley; P. Parham; E. Trachtenberg; X. Luo; C.T. Le; J. Klein; S.G.E. Marsh; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 59 KB

CD34+ Cell Dose and Full Donor Chimerism

✍ S.G. Holtan; W.J. Hogan; M.A. Elliott; D.A. Gastineau; T.G. Call; S.A. Ansell; D 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 62 KB

326: Donor C3435T polymorphism in the mu

✍ A. Shimoni; O. Ostrovsky; H. Galski; I. Hardan; N. Shem-Tov; R. Yerushalmi; A. N 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 64 KB